Viibryd vilazodone regulatory update

FDA approved an NDA from Clinical Data for Viibryd vilazodone to treat major depressive disorder (MDD). Vilazodone is a mixed selective serotonin reuptake inhibitor (SSRI) and partial serotonin (5-HT...